The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia

Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by cognitive decline. Dyslipidemia, a risk factor for AD, may influence the expression of microRNAs (miRs) involved in AD pathogenesis. Thus, the aim of this study was to investigate the effect of dyslipidemia o...

Full description

Bibliographic Details

Published in:	IBRO Neuroscience Reports
Main Authors:	Shahram Darabi, Enam Alhagh Gorgich, Auob Rustamzadeh, Nafiseh Mohebi, Hossein Mozhdehipanah
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	Alzheimer's disease Dyslipidemia Biomarker MiR-133b MiR-206
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242125000624